Cohance Lifesciences Limited (COHANCE.NS)
Cohance Lifesciences Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Hyderabad, TS, IN. The stock last traded at $440.65, down 0.80% on the session, giving a market capitalisation of $168.58B. Its beta of 0.60 implies it has historically moved less than the broad market.
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Cohance Lifesciences Limited is most often compared with the following Healthcare names: